InsiderClue
← All stocks

Janux Therapeutics, Inc.

JANX Net selling
CIK 0001817713 #2496 in the set updated 19 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$1.06M
$0.00 on a plan · $710.91K straight out of an exercise
Sold at will
$347.15K
8 of 12 sales
Net
−$1.06M
−$347.15K against sales at will

By person

19 insiders · 13 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Meyer Andrew Hollman
Chief Business Officer
—
$736.70K (5) scheduled
−$736.70K
83,095
0.1359%
$1.17M
+18.0%
Campbell David Alan
President and CEO
—
$110.83K (1)
−$110.83K
264,742
0.4330%
$3.71M
−20.3%
Doyle Janeen Noel
Chief Corp. & Bus. Dev. Ofcr
—
$56.94K (1)
−$56.94K
75,941
0.1242%
$1.07M
—
Dobek Maria
Vice President, Accounting
—
$48.95K (2)
−$48.95K
32,270
0.0528%
$452.72K
+1,038%
McIver Zachariah
Chief Medical Officer
—
$37.26K (1)
−$37.26K
52,286
0.0855%
$733.52K
—
DiRaimondo Thomas
Chief Scientific Officer
—
$34.39K (1)
−$34.39K
155,825
0.2549%
$2.19M
+44.4%
Winter Charles M.
Chief Technical Officer
—
$32.97K (1)
−$32.97K
106,321
0.1739%
$1.49M
+86.1%
Avalon Ventures XI, L.P. entity
10% owner
—
—
—
4,187,172
6.85%
$58.74M
−32.0%
Gujrathi Sheila
Director
—
—
—
118,889
0.1945%
$1.67M
+7.6%
CAPPS VICKIE L
Director
—
—
—
79,598
0.1302%
$1.12M
+17.0%
Go William
Chief Medical Officer
—
—
—
44,000
0.0720%
$617.28K
—
Robinson Byron
Chief Strategy Officer
—
—
—
28,000
0.0458%
$392.81K
—
DOBMEIER ERIC
Director
—
—
—
15,481
0.0253%
$217.18K
+148.5%
Hernday Natasha
Director
—
—
—
15,481
0.0253%
$217.18K
+148.5%
RA CAPITAL MANAGEMENT, L.P. entity
Director
—
—
—
11,750
0.0192%
$164.84K
—
Simson Jake
Director
—
—
—
11,750
0.0192%
$164.84K
+370.0%
Kung Winston
Director
—
—
—
11,750
0.0192%
$164.84K
+370.0%
Barrett Ronald W
Director
—
—
—
11,750
0.0192%
$164.84K
+370.0%
McNulty Alana B.
Director
—
—
—
6,250
0.0102%
$87.68K
+150.0%

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 22
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 4
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 477,206
History held since 14 Jun 2021